$50 million gift from Linda and John Mellowes puts their name and their hometown faith at the center of precision medicine
Linda Mellowes once wanted to be a doctor.
She grew up in small-town Arkansas, and her family couldn’t pay for medical school.
So she went to Washington, worked on Capitol Hill to save for college, earned a degree in biology and chemistry, and took a job doing hematology research at the National Institutes of Health.
That is where she saw, as she later put it, “how medical research makes a huge difference.”
Six decades later, she and her husband, John, have made one of the largest bets on medical research in Wisconsin history.
The Medical College of Wisconsin announced today that Linda T. and John A. Mellowes, together with the Charter Manufacturing Foundation, have given $50 million to speed the school’s work in precision medicine.
It is the largest investment MCW has ever received for the field, and it ties the largest philanthropic gift in the institution’s history, a $50 million commitment from the Kern Family Foundation in 2022 for medical education.
The gift carries the Mellowes name into two of the most visible places on the Milwaukee campus.
The Center for Genomic Sciences and Precision Medicine, already named for the couple, becomes the Medical College of Wisconsin Linda T. and John A. Mellowes Institute for Genomic Medicine and Precision Therapeutics.
The Hub for Collaborative Medicine, the building at the heart of campus where physicians, researchers, students and industry partners have worked side by side since it opened in 2017, becomes the Medical College of Wisconsin Linda T. and John A. Mellowes Health Innovation Center.
The couple explained the gift as they always have: a matter of home.
“We are proud that we can get exceptional, innovative care right here in our hometown, and we want everyone to have that experience,” they said.
“The Medical College of Wisconsin is a place people trust, and when you’re facing a serious health challenge, getting your health back is all about trust. We hope this gift helps more people receive the care they need close to home.”
Precision medicine starts from a simple observation: no two people are exactly alike, and the same treatment can help one patient and fail another.
By reading a patient’s genome and understanding how genetic differences shape disease, physicians can match prevention, diagnosis and therapy to the person rather than the average.
Milwaukee has a real claim to this field. MCW and clinicians at Children’s Wisconsin were the first in the world to diagnose and treat a patient by sequencing his genome, a case involving a child with a rare disease that helped launch genomic medicine as a clinical practice.
The new money is meant to turn that early lead into an everyday standard. It will build the data systems needed to bring genomic information to the bedside, recruit and keep top scientists and clinicians in Milwaukee, and train future physicians in genomics and data science.
Raising the center to the status of an institute is also strategic. School leaders say it will raise the program’s national profile and help it compete for research funding, and it formalizes MCW’s role as the hub for precision medicine shared with its clinical partners, Children’s Wisconsin and Froedtert ThedaCare Health.
The stated goal is ambitious: to become the first place in the world where lifelong, personalized care is the standard for everyone, beginning with universal genomic sequencing.
The person charged with that goal arrived this month. Marni J. Falk, MD, who built and led the Mitochondrial Medicine Frontier Program at Children’s Hospital of Philadelphia and the University of Pennsylvania’s Perelman School of Medicine, became executive director of the new institute after a national search.
Her work has centered on rare genetic disease, the families who often wait years for a diagnosis, and the treatments that can follow once the cause is found.
“For years, medical treatments have been designed to serve most people,” she said. “Through genomic science, we can better understand what will work best for each individual patient.”
She credited the Mellowes family with “investing in a future where more people can benefit from this personalized approach to care.”
To understand why this gift matters to the couple, it helps to see how long they have been building toward it.
John Mellowes grew up in a Milwaukee manufacturing family.
His grandfather and father ran Charter Manufacturing, founded in 1936, and he followed them to Cornell to study engineering before serving as a Navy lieutenant.
He met Linda while she was working at NIH, and they married in 1965. He started out running a Charter plant in New Jersey, and in 1970 the couple moved to Milwaukee so John could help lead the family business.
He became chairman and chief executive in 1980, just as the American steel industry was collapsing.
Charter survived, and then it flourished.
John’s idea was to make the company a steel producer, not only a steel buyer. Under his leadership, a company with about four plants and roughly $20 million in sales grew into one of the country’s largest specialty steel manufacturers, with more than $1 billion in annual sales and some 2,000 employees worldwide.
He refused to take it public, wary of the short-term pressure he had seen on other boards.
He handed the company to his sons, John W. and Charles, after a carefully planned transition and stepped down as CEO in 2013.
Charter remains entirely owned by the Mellowes family.
Away from the office, John has said, his great hobby is model railroading, which keeps him busy in his basement.
Linda took on a different role.
“As John grew the business, my job was family and community involvement,” she has said.
“One of my biggest goals was to show that our company was philanthropic.”
She began by going door to door for the United Way and eventually became the first woman to chair its board.
She chaired the board of University School of Milwaukee, where John was a student in the 1950s, and has led seven local boards in all.
She joined the MCW Board of Trustees in 1994, chaired it from 2008 to 2010, and led the search that brought in the school’s previous president. Despite calling herself shy, she has become one of Milwaukee’s most effective fundraisers, a woman who, as she told Milwaukee Magazine when it gave her the 2025 Quadracci Family Betty Award, does not see “no” as a final answer.
The award was named for Betty Quadracci, her friend and former next-door neighbor in Shorewood, where the two families raised their children.
The Melloweses have never released a lifetime total for their giving, and no reliable full count exists. Their public record, though, shows that giving at this scale is new for them.
At the Medical College alone, today’s $50 million follows a $10 million commitment in 2022 that first put their name on the genomics center and created three endowed chairs in precision oncology, precision medicine, and bioinformatics and data analytics, along with an endowed fund for innovation and discovery.
That brings their publicly announced gifts to MCW to at least $60 million. Before that, they had endowed a faculty chair in the Department of Medicine and launched the college’s Women’s Health Research Program, giving their own money and persuading other community leaders to join them.
When they made the 2022 gift, John called it the largest they had ever made.
The gift announced now is five times larger.
Beyond the medical school, their giving runs through the whole city.
They have belonged to United Way’s Tocqueville Society, the circle of its most generous individual donors, since 1992.
They sit on its Million Dollar Roundtable.
For more than two decades they have funded the Linda T. and John A. Mellowes Community Impact Challenge, which this year doubles new and increased Tocqueville gifts up to $100,000.
Through the Charter Manufacturing Foundation, which Linda has helped steer and which held about $20 million in assets in its latest public filing, the family gives more than $1 million a year, nearly all of it in Wisconsin.
Recent grants have supported the Milwaukee School of Engineering, where John has served as a board member; the Greater Milwaukee Foundation; the Milwaukee Public Museum; the YMCA; and the Milwaukee Repertory Theater.
The largest single grant in that filing, $500,000, went to MCW to support the Mellowes Fund for Innovation and Discovery.
That pattern of steady, local generosity is what makes today’s gift feel less like a departure than a culmination.
Years ago, when MCW first named the genomics center for them, Linda said that “we want people to know they don’t need to go to the Cleveland Clinic, Mayo, or Johns Hopkins for the best treatment in the world. We want everyone to know they never have to leave Milwaukee.”
She called the gift a long-term investment, “not a quick-fix bandage,” and said that she and John “absolutely want to see results.”
John described it as “a demonstration to others that we believe in this,” and a message to their own family and to Charter’s employees that the company would stay committed to the community those workers call home.
MCW president and CEO Shekar N. Kurpad, MD, PhD, said the latest gift “will reshape how we understand, prevent, diagnose, and treat diseases for generations to come” and will widen access to personalized medicine for people across the region.
The couple, characteristically, ended with an invitation rather than a victory lap.
“There’s always more that can be done to help people,” they said. “We believe our contribution will help bring the benefits of precision medicine to our community, and as more people see the difference it can make, we hope they’ll be inspired to help, too.”